In addition to determining a role for impaired 1,25D signaling due to enhanced FGF23 levels in XLH enthesopathy development, these studies will also define a role for 1,25D in normal postnatal enthesis maturation. The gene discussed is FGF23; the disease is X-linked hypophosphatemia.